RSLS - ReShape Lifesciences Inc.
IEX Last Trade
0.1524
-0.008 -5.446%
Share volume: 699,809
Last Updated: Fri 30 Aug 2024 09:42:54 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$0.16
-0.01
-5.17%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | |
| Report Date | 2022-05-23 | 2022-08-19 | 2022-11-14 | |
| Assets | ||||
| Total Assets | 47.270 M | 41.925 M | 28.456 M | |
| Current Assets | 23.627 M | 19.487 M | 13.573 M | |
| Inventories | 3.998 M | 4.226 M | 4.171 M | |
| Other Current Assets | 1.759 M | 1.269 M | 926.000 K | |
| Short Term Investments | 1.759 M | 1.269 M | 926.000 K | |
| Total Receivables | 2.410 M | 2.448 M | 2.230 M | |
| Current Cash | 15.410 M | 11.494 M | 6.146 M | |
| Total Non-current Assets | 23.643 M | 22.438 M | 14.883 M | |
| Property Plant Equipment | 1.371 M | 887.000 K | 896.000 K | |
| Other Assets | 1.377 M | 1.298 M | 1.219 M | |
| Intangible Assets | 20.371 M | 19.915 M | 12.513 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 47.270 M | 41.925 M | 28.456 M | |
| Total liabilities | 8.645 M | 9.562 M | 7.513 M | |
| Total current liabilities | 8.151 M | 9.190 M | 7.513 M | |
| Accounts Payable | 3.598 M | 2.513 M | 1.992 M | |
| Other liabilities | 41.000 K | 5.000 K | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 41.000 K | 5.000 K | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 38.625 M | 32.363 M | 20.943 M | |
| Common stock | 18.540 M | 19.311 M | 22.559 M | |
| Retained earnings | -584.975 M | -594.551 M | -606.362 M |